1 – 10 of 10
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Inhibition of Thrombin Formation by Active Site Mutated (S360A) Activated Protein C
(
- Contribution to journal › Article
- 2008
-
Mark
Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin
(
- Contribution to journal › Article
-
Mark
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
(
- Contribution to journal › Article
- 2007
-
Mark
Coagulation factorV and thrombophilia: Background and mechanisms
(
- Contribution to journal › Article
-
Mark
The role of thrombin exosites I and II in the activation of human coagulation factor V
(
- Contribution to journal › Article
- 2004
-
Mark
Functional properties of recombinant factor V mutated in a potential calcium-binding site.
(
- Contribution to journal › Article
- 2003
-
Mark
Congenital and acquired activated protein C resistance.
(
- Contribution to journal › Article
-
Mark
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
(
- Contribution to journal › Scientific review
- 2002
-
Mark
Factor V and thrombotic disease: description of a janus-faced protein.
(
- Contribution to journal › Scientific review
-
Mark
Molecular basis of quantitative factor V deficiency associated with factor V R2 haplotype.
(
- Contribution to journal › Article